|
Gabriella Pezzoni was named Scientific Director of CTE in September 2006 with responsibility for preclinical research and development. She was a founding member of the Italian pharmaceutical company Novuspharma with responsibility as Director of Biology prior to its merger with CTI. Before joining Novuspharma, Ms. Pezzoni was head of oncology research at Boehringer Mannheim Italia SpA., where she was responsible for New Drug Applications and Investigational New Drug applications. Before joining Boehringer Mannheim Italia she worked at Farmitalia Carlo Erba Research Centre in Nerviano, Milano (ex Pfizer Inc.) coordinating in vivo anti-tumor activity studies. Ms. Pezzoni has also worked at the Tumour Institute in Milan and holds a degree in biological sciences from the University of Pavia. | 